IGF1 and dementia: Although, the majority of studies report a contribution of alterations in IGF-I signaling to the prediction of dementia risk independent of apolipoprotein E (ApoE) genotype (Vargas et al., 2011; Talbot et al., 2012; van Exel et al., 2014; Lane et al., 2017), Deelen et al. (2011) reported an association between the ApoE-ε4 allele and lowered total serum IGF-I levels in middle-aged women.